Navigation
-
Research
- Research Overview
- Our Impact
-
Research Activities
- 3-D Tissue Bioprinting
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- About LitCoin
- Analytical Chemistry
- Automation
- Biomedical Data Translator
- BrIDGs
- Chemistry Technology
- Clinical Trial Readiness for Rare Diseases, Disorders and Syndromes
- Clinical and Translational Science Awards (CTSA) Program
- Compound Management
- Diagnostic Odyssey
- Functional Genomics Laboratory
- Gene-Targeted Therapies
- Illuminating the Druggable Genome (IDG)
- Informatics
- Matrix Combination Screening
- NIH HEAL
- National Clinical Cohort Collaborative (N3C)
- New Therapeutic Uses
- OpenData Portal
- Quantum Research Activities
- Rare Diseases Clinical Research Network (RDCRN)
- Rare Diseases Registry Program (RaDaR)
- Stem Cell Translation Laboratory (SCTL)
- Stimulating Peripheral Activity to Relieve Conditions (SPARC)
- Therapeutics for Rare and Neglected Diseases (TRND)
- Tissue Chip for Drug Screening
- Toxicology in the 21st Century (Tox21)
- Research Resources
- Training & Education
- Alliances
- Collaborate With NCATS
- Funding
- Resources For You
-
News & Events
- News & Events Overview
-
News
- How NCATS Is Accelerating Drug Discovery: A Behind-the-Scenes Look With NIH Leadership
- WEST AI Algorithm May Help Speed Diagnosis of Rare Diseases
- Neuroimmune Signaling Between the Heart and the Brain May Contribute to Heart Attack Damage
- Rare Disease Day at NIH 2026: Paving the Way to a Brighter Future for All Americans
- Transparency and Early Planning Are Key in Increasing Efficiency of Gene Therapy Development for Rare Diseases
- Tissue Chips in Space 2.0 Will Reveal Age-Related Disease Mechanisms and Possible Therapies
- Rare Diseases Clinical Research Network Awardees Expand the Reach of NIH Impact
- A New 3-D Skin Tissue Model Helps Identify Possible New Treatments for Herpes Simplex Virus
- NIH Combines Traditional High-Throughput Screening and Artificial Intelligence to Fast-Track Probe Discovery for ALDH Enzymes
- NIH More Than Triples Its Investments in Digital Health Technology Research
- A New Algorithm Helps Track Calories Burned for People With Obesity
- Pre-Birth Exposure to Forever Chemicals May Harm the Immune System
- Using Certain Antibiotics During the First Trimester of Pregnancy Raises the Risk of Birth Defects
- An Organ-on-a-Chip Model of ALS Will Help Uncover Early Disease Characteristics and Find Potential Therapies
- Using Artificial Intelligence in Neonatal Intensive Care Units to Guide Effective Nutrition Interventions
- A Decade-Long Program Investigating Understudied Proteins Builds a Foundation for the Future
- New Assay Technology Could Reshape Approach to Drug Discovery
- Turning to AI, NIH Scientists Reveal Promising Pancreatic Cancer Drug Combinations
- Infant with Rare, Incurable Disease is First to Successfully Receive Personalized Gene Therapy Treatment
- Protein in the Blood Can Help Predict ALS Survival and Decline, Play Role in Developing Treatments
- A Promising Strategy to Raise Colorectal Cancer Screening Rates in Rural Areas
- Collaborative Drug Discovery Vault: Banking on Shared Data
- Electronic Consent Summary Form Creates More Participant-Focused Process, Speeds Clinical Trial Enrollment
- NCATS Team Creates Novel Computational Pipeline to Find New Ways to Treat Glioblastoma
- A Combination of Tests Shows Learning Capabilities of Nonverbal Children with Rare Brain Disorder
- Comprehensive Testing Confirms Quality of Tox21 Library’s Chemical Compounds
- NIH More Than Triples Its Investments in Digital Health Technology Research
- NCATS Researchers Help Gene Therapy for AADC Deficiency Gain FDA Approval
- New Screening Tool Could Rapidly Reveal Better Cancer-Drug Combinations
- Tox21 Team Finds Environmental Chemicals That Could Trigger Early Puberty in Girls
- Spectradyne: SBIR Funding Spurs Advances in Nanoparticle Technology
- New Path for a Gene Therapy Trial at NIH for a Rare Metabolic Disease
- New FDA Designations May Jumpstart Gene Therapy Development
- New Drug Screening Funnel Could Speed New Therapies for Gaucher Disease, Parkinson’s
- N3C Study Shows Health Factors Before COVID-19 Infection May Predict Long COVID Risk
- Brain Organoids Help Reveal Antiviral Drug’s Promise in Parkinson’s Disease
- NCATS-Developed Ketamine Alternative Was Safe, Didn’t Cause Dissociation in Phase 1 Clinical Trial
- N3C Study Finds Long COVID More Likely After Initial Infection Than After Reinfection
- NIH-Funded Centers Look to Make Tissue Chips FDA-Ready Tools
- With Gene Editing, Mice with a Form of Inherited Deafness Can Hear Again
- NCATS Report Highlights Decentralized Clinical Trials’ Challenges, Opportunities
- Paving the Way for Ultrarare Bone Disease Treatment Trial
- Rare Disease Day at NIH 2024: Showcasing Voices and New Opportunities
- Using AI to Shape the Future of Treatment Personalization
- N3C-Driven Study Shows COVID-19 Vaccination Did Not Boost Risk of Poor Pregnancy Outcomes
- Scientists Discover Potential Treatment Approaches for Polycystic Kidney Disease
- NCATS Enables a Drug’s Path to FDA Approval for Duchenne Muscular Dystrophy
- Sugar Compound’s Key Role in SARS-CoV-2 Infection May Lead to New COVID-19 Therapies
- NCATS-Funded Rare Disease Researchers Provide Key Data, Help Build New Kidney Atlas
- Repurposed Drug Helps Cells Clear Defective Proteins, Reveals Route to New Therapies
- Breaking Down Prednisone Too Quickly May Short-Circuit Its Benefit for Rare Neuromuscular Disorder
- Electrifying Invention Can Save Young Lives and Ease Chronic Lung Conditions
- Retooled Methotrexate Could Lead to New Therapies for Cancer, Autoimmune Disorders
- Study Suggests Most People May Have Gene Variants That Impact Drugs’ Effectiveness
- CTSA Researchers Use Deep Learning Model to Predict Best Time to Monitor for Atrial Fibrillation
- GEMINI Study Reveals Diagnostic Advantages for Whole-Genome Sequencing in Hospitalized Infants
- Newborn Screening for Rare Immune Disorders Led to Earlier Treatment, Improved Survival
- Scientists Build Ferroptosis Inhibitors to Curb Cell Death Process Linked to Alzheimer’s Disease and Cancer
- N3C Data Help Validate Two Clinical Tools to Predict COVID-19 Mortality Risk
- Can Metformin Treat COVID-19 and Prevent Long COVID? NCATS and Partners Pursue Answers
- New 3-D Models Offer Insights Into the Biology of a Rare, Devastating Neurological Disease
- Efficient Approach Creates Astrocytes Faster From Stem Cells for Drug Development and Regenerative Medicine
- Researchers Show How a Tumor Cell’s Location and Environment Affect Its Identity
- NCATS Scientists Turn Stem Cells Into Vast Supply of Neurons to Better Predict Pain Therapies’ Effectiveness
- Genetics Experts Support Adding Hundreds of Treatable Rare Diseases to Newborn Screening
- Artificial Intelligence Is Advancing Clinical Research and Data Quality
- Better Method for Growing Stem Cells Could Speed Gene-Editing Therapies
- As Flights End, Tissue Chips in Space Projects Offer Glimpses Into the Biology of Aging
- Rare Disease Day at NIH 2023: Putting Hope Into Action
- Scientists Reveal a Potential New Approach to Treating Liver Cancer
- Rural Hospital Closures Fuel Rising Demand and Costs at Nearby Hospitals
- Analysis Reveals Nationwide Spread of Three Historically Regional and Potentially Life-Threatening Fungal Infections
- New 3-D Model Offers Insights into the Role of Glucose in a Deadly Kidney Disease
- Efficient Registry Approach Powers Practice-Shaping Infant Heart Surgery Trial
- Previous Common Colds Could Boost Risks of More Severe COVID-19
- N3C Data Reveal More Severe COVID-19 Outcomes in Rural Communities
- Mount Sinai, NCATS Scientists Uncover a Potential New Path Against Neurological Disease
- Tiny Antibodies May Provide New Tool to Fight COVID-19
- Nationwide IRB Reliance Agreement Aimed at Speeding Research Reaches 1,000 Signatories
- COVID-19 Hospitalization May Increase Heart Failure Risk
- Media Advisory: To Find Answers for People on Earth, NIH-Funded Tissue Chip Models Take Flight
- Immune Modulator Drugs Improved Survival for People Hospitalized with COVID-19
- Scientists Identify Characteristics to Better Define Long COVID
- Rare Disease Day at NIH 2022: Shining a Light on Patient Perspectives
- Researchers Use Cutting-Edge EHR Data Resource to Find Risk Factors for Severe COVID-19 in Children
- Researchers Create 3-D Model for Rare Neuromuscular Disorders, Setting Stage for Clinical Trial
- NCATS BioPlanet: A Resource for Discovery
- NCATS’ Screening Studies Focus on Making Melanoma Cells More Visible, Advancing Efforts to Overcome Roadblock in Therapy
- Ketogenic Diet May Offer a New Approach to Treating Alzheimer’s Disease
- NCATS-Supported Research Reduces Time to Diagnosis for Seriously Ill Children with Genetic Diseases
- NCATS, Duke Scientists Show Compound’s Novel Effects on Key Brain Chemical in Drug Addiction
- An Itch to Scratch: NCATS, NIDCR Scientists Identify Potential New Approach to Chronic Problem
- Robots Could Spur Use of Stem Cells in the Laboratory and Clinic
- International Registry Reveals Risks COVID-19 Poses with Sickle Cell Disease
- Statement on NIH Study Testing Convalescent Plasma in Hospitalized Patients
- NCATS News - Thank You
- Newsletters
- Events
- Scientific Publications
- Multimedia
- About NCATS